Industry thought leaders will share how LifeSphere is building the security products of the future today.
MIAMI, September 21, 2022 /PRNewswire/ — ArisGlobal, the leading life sciences software provider that automates core drug development functions with its end-to-end LifeSphere® technology platform, today announces a series of technology- and data-centric sessions at the 2022 World Drug Safety Congress (WDS ) events, including a keynote address from the Chief Commercial Officer Aman Wasan at WDS Europe, followed by WDS Americas, with a keynote session from LifeSphere Safety product leader and acclaimed industry veterans, Beena wood.
The world tour will kick off with a series of talks at WDS Europe with three informative sessions over two days. Attendees will hear Wasan join other innovative speakers to discuss the data and analytics opportunities in pharmacovigilance, including hot topics such as using intelligent analytics to unlock insights from data and how ArisGlobal’s LifeSphere solutions are driving pharmacovigilance today and tomorrow driving innovation.
Following Breakthrough, the company’s signature event, ArisGlobal’s LifeSphere Safety product leaders will once again take the stage at the WDS Americas event for three additional sessions. Specifically, ArisGlobal will have a conversation with safety leaders from Boehringer Ingelheim, Moderna and PMI on a panel discussing results from the practice of pharmacovigilance automation.
“We are excited to speak at World Drug Safety and share our views on the future of R&D IT strategy and how technology is playing a key role in the digital transformation of the life sciences IT ecosystem,” said Wasan. “ArisGlobal’s LifeSphere is at the forefront of strategic innovation to continue advancing the industry, and we’re proud to usher in the next generation of technology and data.”
Recently, ArisGlobal acquired an advanced intelligent analytics engine from Boehringer Ingelheim, LifeSphere Clarity, which will be showcased at ArisGlobal’s Breakthrough conference and will debut as a commercially available product in 2023, bringing enhanced and unmatched data intelligence capabilities to the life sciences.
ArisGlobal: ArisGlobal is led by passionate individuals who help life sciences leaders develop and monitor breakthrough medicines and therapies. With more than 35 years of experience in the life sciences industry, ArisGlobal develops technology products within the LifeSphere platform to advance pharmaceutical and biotechnology research and development. Building on our commitment to corporate social responsibility and sustainability initiatives, we give back to the communities in which we live and work.